Effectiveness of a lifestyle toolkit in improving health outcomes in individuals with cardio-metabolic multi-morbidity and inter-generational prevention; a cluster rondomized controlled trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- Primary Outcomes- Change in glycaemic control (HbA1c)
研究概览
简要总结
Lifestyle modification, including dietary interventions, physical activity, and stress management, has proven crucial in the non-pharmacological management of cardiometabolic risk factors. However, the efficacy of these interventions in the context of cardiometabolic multimorbidity (CMM) within the unique demographic and cultural milieu of India is inadequately explored, despite Indians exhibiting distinct susceptibility to cardiovascular diseases. This study aims to address existing knowledge gaps by assessing the effectiveness of a culturally tailored lifestyle toolkit based on the WHO-HEARTS framework in improving health outcomes among individuals with CMM and exploring the intergenerational preventive dimension. The study adopts a two-arm non-blinded Cluster Randomised Controlled Trial design to include adults diagnosed with CMM, defined by the presence of diabetes mellitus, stroke, or heart disease, aged 18 years and above, providing informed consent, and agreeing to follow-up. The trial spans three cohorts in Ernakulam (Kerala), Tigiria (Odisha), and Sheragada (Odisha), encompassing a total population of 330,055. The intervention, a ’lifestyle toolkit,’ integrates guidance on diet, physical activity, stress management, tobacco and alcohol cessation, and drug adherence. It leverages community health volunteers and an M-health platform for implementation. The comparator is Standard of Care (SoC), involving patient-initiated physician visits. Primary outcomes include changes in glycaemic control (HbA1c), while secondary outcomes encompass changes in blood pressure, body mass index, quality of life scores, diet patterns, stress levels, tobacco and alcohol usage, drug adherence, and physical activity. Measurements involve point-of-care devices and digital tools. The study duration is 36 months, with a sample size of 2000 participants distributed across 40 clusters. Statistical analysis includes repeated-measures ANOVA and multilevel models, employing an intention-to-treat approach. The study’s novelty lies in its holistic approach, addressing various facets of CMM comprehensively.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant and Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 75.00 Year(s)(—)
- 性别
- All
入选标准
- •Individuals diagnosed with Cardiometabolic Multimorbidity (CMM), defined as the concurrent presence of two or more of the following conditions: diabetes mellitus, stroke, or heart disease.
- •Identified individuals with CMM from the cohorts at Ernakulam, Tigiria and Sheragada.
排除标准
- •Individuals with cognitive impairment impeding their ability to follow instructions.
- •Bedridden individuals.
- •Individuals with other significant confounding health conditions, such as malignancy or chronic airway disease.
- •Individuals aged 75 years or older.
- •Individuals diagnosed with a terminal medical condition.
- •Pregnant or lactating mothers.
结局指标
主要结局
Primary Outcomes- Change in glycaemic control (HbA1c)
时间窗: 1st March 2024 to 28th February 2026
Secondary outcomes – Change in systolic and diastolic blood pressure, BMI, Quality of life (QoL) scores, diet & nutrition patterns, stress levels, tobacco and alcohol usage, adherence to drugs and physical activity.
时间窗: 1st March 2024 to 28th February 2026
次要结局
- econdary outcomes – Change in systolic and diastolic blood pressure, BMI, Quality of life (QoL) scores, diet & nutrition patterns, stress levels, tobacco and alcohol usage, adherence to drugs and physical activity.
研究者
Jaideep C Menon
Amrita Institute of Medical Sciences
